James L Wade

  • 8864 Citations
1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Certifications and Licenses

Internal Medicine
Medical Oncology

Training Experience

1981Residency, Univ. of Illinois Hospital
1984Fellowship, University of Chicago Hospitals

Education/Academic qualification

MD, University of Illinois at Chicago

… → 1978

Fingerprint Dive into the research topics where James L Wade is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 8864 Citations
  • 72 Article
  • 11 Review article

Clinical assessment of 5-fluorouracil/leucovorin, nab-paclitaxel, and irinotecan (folfirabrax) in untreated patients with gastrointestinal cancer using UGT1A1 genotype–guided dosing

Joshi, S. S., Catenacci, D. V. T., Karrison, T. G., Peterson, J. D., Zalupski, M. M., Sehdev, A., Wade, J., Sadiq, A., Picozzi, V. J., Amico, A., Marsh, R., Kozloff, M. F., Polite, B. N., Kindler, H. L. & Sharma, M. R., Jan 1 2020, In : Clinical Cancer Research. 26, 1, p. 18-24 7 p.

Research output: Contribution to journalArticle

  • Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202

    Henry, N. L., Unger, J. M., Till, C., Schott, A. F., Crew, K. D., Lew, D. L., Fisch, M. J., Moinpour, C. M., Wade, J. L. & Hershman, D. L., Jun 15 2019, In : Cancer. 125, 12, p. 2123-2129 7 p.

    Research output: Contribution to journalArticle

  • Effective stakeholder engagement: Design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care

    Barger, S., Sullivan, S. D., Bell-Brown, A., Bott, B., Ciccarella, A. M., Golenski, J., Gorman, M., Johnson, J., Kreizenbeck, K., Kurttila, F., Mason, G., Myers, J., Seigel, C., Wade, J. L., Walia, G., Watabayashi, K., Lyman, G. H. & Ramsey, S. D., Jun 11 2019, In : BMC Medical Research Methodology. 19, 1, 119.

    Research output: Contribution to journalArticle

    Open Access
  • Randomized phase II trial of cisplatin and etoposide in combination with veliparib or placebo for extensive-stage small-cell lung cancer: ECOG-ACRIN 2511 study

    Owonikoko, T. K., Dahlberg, S. E., Sica, G. L., Wagner, L. I., Wade, J. L., Srkalovic, G., Lash, B. W., Leach, J. W., Leal, T. B., Aggarwal, C. & Ramalingam, S. S., Jan 20 2019, In : Journal of Clinical Oncology. 37, 3, p. 222-229 8 p.

    Research output: Contribution to journalArticle

  • 20 Scopus citations

    SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

    Langer, C. J., Redman, M. W., Wade, J. L., Aggarwal, C., Bradley, J. D., Crawford, J., Stella, P. J., Knapp, M. H., Miao, J., Minichiello, K., Herbst, R. S., Kelly, K., Gandara, D. R. & Papadimitrakopoulou, V. A., Oct 2019, In : Journal of Thoracic Oncology. 14, 10, p. 1839-1846 8 p.

    Research output: Contribution to journalArticle

  • 4 Scopus citations